Article
Novel drug metabolism indices for pharmacogenetic functional status based on combinatory genotyping of CYP2C9, CYP2C19 and CYP2D6 genes.
Biomarkers in medicine - 1 Aug 2011
Villagra David, Goethe John, Schwartz Harold I, Szarek Bonnie, Kocherla Mohan, Gorowski Krystyna, Windemuth Andreas, Ruaño Gualberto
Abstract excerpt
AIMS: We aim to demonstrate clinical relevance and utility of four novel drug-metabolism indices derived from a combinatory (multigene) approach to CYP2C9, CYP2C19 and CYP2D6 allele scoring. Each index considers all three genes as complementary components of a liver enzyme drug metabolism system and uniquely benchmarks innate hepatic drug metabolism reserve or alteration through CYP450 combinatory genotype...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
